Literature DB >> 4048886

Adenosine spares platelets during cardiopulmonary bypass in man without causing systemic vasodilatation.

A Sollevi, L Torssell, B B Fredholm, G Settergren, M Blombäck.   

Abstract

The effect of infusing adenosine during cardiopulmonary bypass (CPB) on platelet count and mean arterial blood pressure (MABP) was studied in 13 patients (age 42-74), with 12 patients (age 47-66) as controls. Adenosine infusion (0.1 mg/kg/min in a central vein) caused a ten- to twentyfold increase of the adenosine concentration in the venous blood to the oxygenator, while the arterial levels were close to basal values (0.3 +/- 0.1 microM). The platelet count was significantly higher in the treated than in the placebo group during and 30 min after CPB, but not on the postoperative day. The groups did not differ with regard to the postoperative blood loss from tube drainage. Adenosine did not cause major systemic vasodilation (MABP less than 30 mmHg) in any case, and the blood pressure levels showed no intergroup difference during CPB. However, seven control patients but none in the adenosine group required vasodilator treatment (sodium nitroprusside) during CPB to prevent MABP from exceeding 70 mmHg. We conclude that adenosine infusion during CPB in man spares platelets, with minor changes in blood pressure.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4048886     DOI: 10.3109/14017438509102711

Source DB:  PubMed          Journal:  Scand J Thorac Cardiovasc Surg        ISSN: 0036-5580


  6 in total

1.  Adenosine: an importance beyond ATP.

Authors:  A H Watt; P A Routledge
Journal:  Br Med J (Clin Res Ed)       Date:  1986-12-06

2.  Effect of infused adenosine on cardiac output and systemic resistance in normal subjects.

Authors:  A Bush; C M Busst; B Clarke; P J Barnes
Journal:  Br J Clin Pharmacol       Date:  1989-02       Impact factor: 4.335

3.  Adenosine in heart and lung disease. Proceedings of the first Cardiothoracic Institute Workshop. 30 March 1988, London. Abstracts.

Authors: 
Journal:  Postgrad Med J       Date:  1988-10       Impact factor: 2.401

Review 4.  Adenosine. An evaluation of its use in cardiac diagnostic procedures, and in the treatment of paroxysmal supraventricular tachycardia.

Authors:  D Faulds; P Chrisp; M M Buckley
Journal:  Drugs       Date:  1991-04       Impact factor: 9.546

Review 5.  Purine metabolism in the heart. Strategies for protection against myocardial ischaemia.

Authors:  K Ver Donck
Journal:  Pharm World Sci       Date:  1994-04-15

6.  Adenosine reduces postbypass transfusion requirements in humans after heart surgery.

Authors:  R M Mentzer; P S Rahko; C C Canver; P S Chopra; R B Love; T D Cook; M O Hegge; R D Lasley
Journal:  Ann Surg       Date:  1996-10       Impact factor: 12.969

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.